Literature DB >> 2925788

An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria.

C J Danpure1, P J Cooper, P J Wise, P R Jennings.   

Abstract

Most patients with the autosomal recessive disease primary hyperoxaluria type 1 (PH1) have a complete deficiency of alanine/glyoxylate aminotransferase (AGT) enzyme activity and immunoreactive protein. However a few possess significant residual activity and protein. In normal human liver, AGT is entirely peroxisomal, whereas it is entirely mitochondrial in carnivores, and both peroxisomal and mitochondrial in rodents. Using the techniques of isopycnic sucrose and Percoll density gradient centrifugation and quantitative protein A-gold immunoelectron microscopy, we have found that in two PH1 patients, possessing 9 and 27% residual AGT activity, both the enzyme activity and immunoreactive protein were largely mitochondrial and not peroxisomal. In addition, these individuals were more severely affected than expected from the levels of their residual AGT activity. In these patients, the PH1 appears to be due, at least in part, to a unique trafficking defect, in which peroxisomal AGT is diverted to the mitochondria. To our knowledge, this is the first example of a genetic disease caused by such interorganellar rerouting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925788      PMCID: PMC2115519          DOI: 10.1083/jcb.108.4.1345

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  35 in total

Review 1.  Peroxisomal disorders: a newly recognised group of genetic diseases.

Authors:  R B Schutgens; H S Heymans; R J Wanders; H van den Bosch; J M Tager
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

2.  Cloning and expression in Escherichia coli of cDNA for serine: pyruvate aminotransferase of rat liver.

Authors:  T Oda; N Kitamura; S Nakanishi; A Ichiyama
Journal:  Eur J Biochem       Date:  1985-08-01

3.  Subcellular distribution of pyruvate (glyoxylate) aminotransferases in rat liver.

Authors:  T Noguchi; Y Minatogawa; Y Takada; E Okuno; R Kido
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

4.  The subcellular distribution of alanine-glyoxylate aminotransferase and serine-pyruvate aminotransferase in dog liver.

Authors:  E Okuno; Y Minatogawa; J Nakanishi; M Nakamura; N Kamoda; M Makino; R Kido
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

Review 5.  How are proteins imported into mitochondria?

Authors:  G Schatz; R A Butow
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

Review 6.  How mitochondria import proteins.

Authors:  R Hay; P Böhni; S Gasser
Journal:  Biochim Biophys Acta       Date:  1984-01-27

7.  In vitro synthesis of a putative precursor of serine: pyruvate aminotransferase of rat liver mitochondria.

Authors:  T Oda; A Ichiyama; S Miura; M Mori; M Tatibana
Journal:  Biochem Biophys Res Commun       Date:  1981-09-16       Impact factor: 3.575

8.  The evolution of peroxisomal and mitochondrial alanine: glyoxylate aminotransferase 1 in mammalian liver.

Authors:  Y Takada; T Noguchi
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

9.  Induction of serum: pyruvate aminotransferase in rat liver organelles by glucagon and a high-protein diet.

Authors:  T Oda; M Yanagisawa; A Ichiyama
Journal:  J Biochem       Date:  1982-01       Impact factor: 3.387

10.  Peroxisomal localization of alanine: glyoxylate aminotransferase in human liver.

Authors:  T Noguchi; Y Takada
Journal:  Arch Biochem Biophys       Date:  1979-09       Impact factor: 4.013

View more
  48 in total

1.  The many roles of oxalate in nature.

Authors:  Lynwood H Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  Alternative topogenic signals in peroxisomal citrate synthase of Saccharomyces cerevisiae.

Authors:  K K Singh; G M Small; A S Lewin
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Separate information required for nuclear and subnuclear localization: additional complexity in localizing an enzyme shared by mitochondria and nuclei.

Authors:  A M Rose; P B Joyce; A K Hopper; N C Martin
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 4.  Import of proteins into peroxisomes and other microbodies.

Authors:  M J de Hoop; G Ab
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

5.  Diet and the frequency of the alanine:glyoxylate aminotransferase Pro11Leu polymorphism in different human populations.

Authors:  Elizabeth F Caldwell; Lianne R Mayor; Mark G Thomas; Christopher J Danpure
Journal:  Hum Genet       Date:  2004-10-05       Impact factor: 4.132

6.  Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors:  C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

Review 7.  Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.

Authors:  C J Danpure; P R Jennings; P Fryer; P E Purdue; J Allsop
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 8.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.

Authors:  Michael J Lumb; Graeme M Birdsey; Christopher J Danpure
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.